Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2020 Filed Mar 30, 2020 17:20 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 4,000 | $4.18 | $16,720.00 |
DisclosureSEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,625,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 26, 2020 Filed Mar 26, 2020 18:08 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,000 | $4.44 | $4,440.00 |
DisclosureSEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,621,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 18:08 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 2,000 | $4.40 | $8,800.00 |
DisclosureSEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,620,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 17:24 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 2,000 | $4.31 | $8,620.00 |
DisclosureSEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,618,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 17:24 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 4,000 | $4.15 | $16,600.00 |
DisclosureSEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,616,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 17, 2020 Filed Mar 17, 2020 20:05 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 3,440 | $4.00 | $13,760.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 6 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,612,601 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:05 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 600 | $4.15 | $2,490.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,609,161 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:05 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 3,000 | $4.28 | $12,840.00 |
DisclosureSEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,608,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 17:09 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 4,000 | $4.20 | $16,800.00 |
DisclosureSEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,605,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 17:09 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 231 | $4.22 | $974.82 |
DisclosureSEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,601,561 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 16:24 UTC |
Smith Ernest S.SVP, Research & CSO
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0000891839-20-000052 · edgar.xml · derivative · entry 5 Smith Ernest S. · CIK 0001747769 · SVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-02-24 F4 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 16:25 UTC |
Zauderer MauriceDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 28,400 | $0.00 Strike: $6.68 | $0.00 |
DisclosureSEC source: 0000891839-20-000054 · edgar.xml · derivative · entry 9 Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,400 Underlying: Common Stock · 28,400 shares Expires 2025-02-24 F5 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 16:25 UTC |
Leonard John E.SVP, Development
|
GrantStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0000891839-20-000053 · edgar.xml · derivative · entry 5 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2030-02-24 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 16:23 UTC |
Watkins Raymond E.SVP & Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0000891839-20-000051 · edgar.xml · derivative · entry 6 Watkins Raymond E. · CIK 0001747774 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-02-24 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 16:23 UTC |
Royer Scott E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0000891839-20-000050 · edgar.xml · derivative · entry 4 Royer Scott E. · CIK 0001747756 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2030-02-24 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 16:24 UTC |
Frieberg Jacob B.Director
|
PurchaseCommon Stock | 39,292 | $5.09 | $199,996.28 |
DisclosureSEC source: 0000891839-20-000033 · edgar.xml · nonDerivative · entry 1 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,292 Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 16:25 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 982,318 | $5.09 | $4,999,998.62 |
DisclosureSEC source: 0000891839-20-000034 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 7,601,330 F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 16:23 UTC |
Zauderer MauriceDirector · President and CEO · 10% owner
|
PurchaseCommon Stock | 98,231 | $5.09 | $499,995.79 |
DisclosureSEC source: 0000891839-20-000032 · edgar.xml · nonDerivative · entry 4 Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Vaccinex (Rochester), L.L.C. Disclosed balance after: 1,097,753 F2 · ownership.nature: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2019 Filed Jan 6, 2020 16:33 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,737 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0000891839-20-000017 · edgar.xml · derivative · entry 8 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,737 Underlying: Common Stock · 2,737 shares Expires 2029-12-28 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| December 31, 2019 Filed Jan 6, 2020 16:34 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,737 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0000891839-20-000018 · edgar.xml · derivative · entry 7 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,737 Underlying: Common Stock · 2,737 shares Expires 2029-12-28 F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 08:40 UTC |
VACCINEX, INC.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-051418 · doc4.xml · derivative · entry 7 VACCINEX, INC. · CIK 0001205922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 07:59 UTC |
VACCINEX, INC.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-051415 · doc4.xml · derivative · entry 6 VACCINEX, INC. · CIK 0001205922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 4, 2019 10:56 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-052505 · doc4.xml · derivative · entry 7 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 4, 2019 11:36 UTC Amendment |
VACCINEX, INC.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-052508 · doc4a.xml · derivative · entry 6 VACCINEX, INC. · CIK 0001205922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 4, 2019 11:22 UTC Amendment |
VACCINEX, INC.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-052507 · doc4a.xml · derivative · entry 7 VACCINEX, INC. · CIK 0001205922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Oct 4, 2019 10:57 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0001209191-19-052506 · doc4.xml · derivative · entry 6 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2019-09-27 F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| September 30, 2019 Filed Jan 6, 2020 16:30 UTC Amendment |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0000891839-20-000015 · edgar.xml · derivative · entry 1 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2029-09-27 F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exerccisable. F1 · derivative.expiration_date: The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date. Read SEC document |
| September 30, 2019 Filed Jan 6, 2020 16:32 UTC Amendment |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,856 | $0.00 Strike: $7.17 | $0.00 |
DisclosureSEC source: 0000891839-20-000016 · edgar.xml · derivative · entry 1 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 Underlying: Common Stock · 1,856 shares Expires 2029-09-27 F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. F1 · derivative.expiration_date: The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 16:30 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,838,235 | $4.08 | $7,499,998.80 |
DisclosureSEC source: 0000891839-19-000142 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 6,619,012 F3 · balance_after: This Form 4 corrects a prior inadvertent administrative error as to the total beneficial ownership reported. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 16:31 UTC |
Zauderer MauriceDirector · President and CEO · 10% owner
|
PurchaseCommon Stock | 183,824 | $4.08 | $750,001.92 |
DisclosureSEC source: 0000891839-19-000143 · edgar.xml · nonDerivative · entry 4 Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Vaccinex (Rochester), L.L.C. Disclosed balance after: 999,522 F2 · ownership.nature: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 26, 2019 Filed Jul 29, 2019 16:37 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,000 | $3.99 | $3,990.00 |
DisclosureSEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,791,521 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 16:37 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 52 | $3.99 | $207.48 |
DisclosureSEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 4 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,790,521 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2019 Filed Jan 15, 2020 16:20 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,385 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0000891839-20-000029 · edgar.xml · derivative · entry 7 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,385 Underlying: Common Stock · 2,385 shares Expires 2029-06-29 F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| June 30, 2019 Filed Jan 15, 2020 16:20 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,385 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0000891839-20-000030 · edgar.xml · derivative · entry 6 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,385 Underlying: Common Stock · 2,385 shares Expires 2029-06-29 F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:40 UTC |
MANIAN BALA SDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000069 · edgar.xml · derivative · entry 1 MANIAN BALA S · CIK 0000941871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F1 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:44 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000072 · edgar.xml · derivative · entry 6 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F6 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:49 UTC |
Goater JeffDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000076 · edgar.xml · derivative · entry 4 Goater Jeff · CIK 0001656435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:41 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000070 · edgar.xml · derivative · entry 5 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:42 UTC |
Berlin Alejandro M.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000071 · edgar.xml · derivative · entry 2 Berlin Alejandro M. · CIK 0001747958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:37 UTC |
Yanni BarbaraDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0000891839-19-000068 · edgar.xml · derivative · entry 2 Yanni Barbara · CIK 0001610561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires not disclosed F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 16:28 UTC |
Frieberg Jacob B.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,501 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0000891839-19-000057 · edgar.xml · derivative · entry 5 Frieberg Jacob B. · CIK 0001748346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,501 Underlying: Common Stock · 2,501 shares Expires 2029-03-30 F6 · shares: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. F6 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. F6 · derivative.exercise_date: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 16:31 UTC |
Van Strydonck, Gerald E.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,501 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0000891839-19-000058 · edgar.xml · derivative · entry 4 Van Strydonck, Gerald E. · CIK 0001748247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,501 Underlying: Common Stock · 2,501 shares Expires 2029-03-30 F2 · shares: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. F2 · derivative.exercise_date: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 17:59 UTC Amendment |
FRIEDBERG ALBERTDirector · 10% owner
Vaccinex (Rochester), L.L.C.10% owner
|
PurchaseCommon Stock | 1,000 | $3.96 | $3,960.00 |
DisclosureSEC source: 0000891839-19-000042 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner Vaccinex (Rochester), L.L.C. · CIK 0001747866 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,790,469 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 17:28 UTC |
FRIEDBERG ALBERTDirector · 10% owner
FCMI Parent Co.10% owner
|
PurchaseCommon Stock | 1,000 | $3.96 | $3,960.00 |
DisclosureSEC source: 0000891839-19-000040 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner FCMI Parent Co. · CIK 0001678258 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,790,469 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:30 UTC |
FRIEDBERG ALBERTDirector · 10% owner
Vaccinex (Rochester), L.L.C.10% owner
|
PurchaseCommon Stock | 1,000 | $3.96 | $3,960.00 |
DisclosureSEC source: 0000891839-19-000038 · edgar.xml · nonDerivative · entry 5 FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner Vaccinex (Rochester), L.L.C. · CIK 0001747866 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By FCMI Parent Co. Disclosed balance after: 4,790,469 F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019. F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 17:04 UTC |
Smith Ernest S.SVP, Research & CSO
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-19-000049 · edgar.xml · derivative · entry 4 Smith Ernest S. · CIK 0001747769 · SVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2029-03-14 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 17:04 UTC |
Zauderer MauriceDirector · President and CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.29 | $0.00 |
DisclosureSEC source: 0000891839-19-000052 · edgar.xml · derivative · entry 9 Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-03-14 F5 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 16:49 UTC |
Royer Scott E.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-19-000051 · edgar.xml · derivative · entry 3 Royer Scott E. · CIK 0001747756 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2029-03-14 F2 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 16:49 UTC |
Watkins Raymond E.SVP & Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-19-000050 · edgar.xml · derivative · entry 5 Watkins Raymond E. · CIK 0001747774 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2029-03-14 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 16:48 UTC |
Leonard John E.SVP, Development
|
GrantStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0000891839-19-000048 · edgar.xml · derivative · entry 4 Leonard John E. · CIK 0001747997 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2029-03-14 F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.